Diabetes drugs that may soon be prescribed more widely in England could save thousands of lives each year, suggests a new study by researchers at UCL and the London School of Hygiene & Tropical Medicine (LSHTM). Last August the UK diabetes guideline committee at the National Institute for Health and Care Excellence (NICE) proposed SGLT-2 inhibitors alongside another drug, metformin, as a first-line treatment for people with type 2 diabetes. The final guidance is expected to be released on 18